RCKT

NASDAQRocket Pharmaceuticals Inc
Tide · No score yetSqueeze · Watch 38Neutral0 buys · -$31KSocial · No data 0
$3.66
$-0.12 (-3.17%)
15-min delayed · Aug 26, 6:21 PMReal-time

Score summary

Buy
Analyst Ratings
7Ratings
4 Buy1 Hold2 Sell
Tide Score
Squeeze Score
38
Watch ·
  • Days to cover11.90
  • Short interest24.22% of float
  • Borrow rate34.76%
  • Short interest trend-0.99% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · -$31k · 14d · 4 super investors

Key statistics

Market Cap
Data pending
52-week range
$0.00 – $0.00
0% from low
Day range
$0 – $0
Open $0.00
Volume
0
vs 0 avg
P/E (TTM)
Fwd —
Earnings

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 7 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$10
7 Wall St 12-month targets
High
$263
Average
$45
Low
$3
Forecast chart unavailable — not enough recent price history or analyst targets for this ticker yet.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 57/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.